NYSE:GPS

Delisted

Gap (the) Stock News

Consumer Cyclical > Apparel - Retail

Buy GPS

*Your capital is at risk

$24.55

+0 (+0%)

At Close: Nov 19, 2024

Gap Inc. to Report Third Quarter Fiscal 2024 Results on November 21

04:15pm, Thursday, 31'st Oct 2024

SAN FRANCISCO , Oct. 31, 2024 /PRNewswire/ -- Gap Inc. (NYSE: GAP) will report its third quarter fiscal 2024 financial results by press release on November 21, 2024, at approximately 1:15 p.m. Pacifi

Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company

03:28pm, Tuesday, 29'th Oct 2024

WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf

The Gap: Looking For A Turnaround Continuation In Q3 (Rating Upgrade)

12:12pm, Monday, 28'th Oct 2024

The Gap, Inc.'s Q3 report is important as the company needs to show continued progress in the recently successful brand turnaround. A weak consumer weighs on the Q3 outlook, causing a more moderate gr

Is The Gap (GAP) a Great Value Stock Right Now?

10:45am, Friday, 25'th Oct 2024

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest

Closing the Justice Gap: Thomson Reuters Launches Programs to Empower Legal Aid and Support the Judiciary

09:00am, Thursday, 24'th Oct 2024

AI for Justice Legal Aid - Thomson Reuters announces first Legal Innovators Incubator class and subsidized CoCounsel pricing for legal aid organizations (LSOs). AI Policy Consortium - New initiatives

Moody's: Solid Q3 2024 Performance And Valuation Gap To SPGI Is Closing

11:33am, Wednesday, 23'rd Oct 2024

I reiterate my hold rating for Moody's due to its valuation premium compared to S&P Global, despite strong fundamentals. MCO's 3Q24 earnings report showed impressive revenue and EPS growth, driven by

Gap Stock Rises 9% in a Month: Should You Buy Now or Wait?

01:15pm, Monday, 21'st Oct 2024

GAP is well-positioned for long-term growth, supported by its strategic focus on improving brands and maintaining financial and operational rigor.

New Economic Report Finds Total Quantified Value of a Terrestrial GPS Backup is $14.6 Billion

09:15am, Monday, 21'st Oct 2024

NextNav's Next-Generation 3D Terrestrial PNT Solution in Lower 900 MHz Band has Potential to Save US Economy $663 Million for One Day of a Global GPS Outage NextNav's Next-Generation 3D Terrestrial PN

What's Driving Gap's Stock Price?

09:00am, Friday, 18'th Oct 2024

Note: Gap's FY'23 ended on February 3, 2024.

SELLAS Announces U.S. FDA Rare Pediatric Disease Designation (RPDD) Granted to Galinpepimut-S (GPS) for the Treatment of Pediatric Acute Myeloid Leukemia

08:45am, Tuesday, 15'th Oct 2024

- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024 - - RPDD Provides Eligibility for GPS to Receive a Priority Review Voucher (PRV) U

Tevogen CEO Reaffirms the Company's Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue Projections

06:43pm, Monday, 14'th Oct 2024

WARREN, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by